| William Stephen Barnes Ii, DMD | |
|
2500 Metrohealth Dr, Cleveland, OH 44109-1900 | |
| (216) 778-7800 | |
| Not Available |
| Full Name | William Stephen Barnes Ii |
|---|---|
| Gender | Male |
| Speciality | Dentist - Oral And Maxillofacial Surgery |
| Location | 2500 Metrohealth Dr, Cleveland, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003017807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | 30022017 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Stephen Barnes Ii, DMD 4492 Saint Germain Blvd, Cleveland, OH 44128-6204 Ph: () - | William Stephen Barnes Ii, DMD 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 778-7800 |
News Archive
In contrast to previous hypotheses, researchers from the University College London and Great Ormond Street Hospital for Children NHS Foundation Trust found no evidence of unique viral sequences from patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). Their study is published on the medRxiv* preprint server.
Michael Hendzel knows all too well that there is little that people can do to control the stability of their genetic code. But he hopes his latest research will help impact this elusive and crucial aspect of medicine. Published in Nature Cell Biology, this research explores a previously unknown secret to DNA repair.
Patients who have been taking opioid pain relievers for several months before spinal fusion surgery are at increased risk of complications after their surgery, reports a study in the journal Spine, published by Wolters Kluwer.
The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.
› Verified 4 days ago
Dr. Joi S. Copeland, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-4725 Fax: 216-778-1787 | |
Javier Alejandro Rodriguez Del Rey, Dentist Medicare: Not Enrolled in Medicare Practice Location: 4071 Lee Rd Ste 260, Cleveland, OH 44128 Phone: 216-368-7238 | |
Dr. Ariel Delgado, Dentist Medicare: Not Enrolled in Medicare Practice Location: 4071 Lee Rd Ste 260, Cleveland, OH 44128 Phone: 216-368-7238 | |
Shelly K Haas, DMD Dentist Medicare: Medicare Enrolled Practice Location: 14601 Puritas Avenue, Cleveland, OH 44135 Phone: 216-671-5452 Fax: 216-671-5455 | |
Dr. Craig Francis Mangie, DDS Dentist Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Deska71, Cleveland, OH 44195 Phone: 216-444-4802 Fax: 216-445-8570 | |
Dr. Terri Thao Tran, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 8101 Euclid Ave, Cleveland, OH 44103 Phone: 216-229-2500 |